1. 1) Antonescu, C. R., et al.: Myxoid Liposarcoma. WHO Classification of Tumors of Soft Tissue and Bone, pp.39-41. Edited by Fletcher, CDM. et al., Lyon, IARC press, 2013.
2. 2) Brenner, W., et al.: Risk assessment in liposarcoma patients based on FDG PET imaging. Eur. J. Nucl. Med. Mol. Imaging, 33: 1290-1295, 2006.
3. 3) Folpe, A. L., et al.: (F-18)fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin. Cancer Res., 64: 1279-1287, 2000.
4. 4) Hamada, K., et al.: 18F-FDG-PET of musculoskeletal tumors: a correlation with the expression of glucose transporter 1 and hexokinase II. Ann. Nucl. Med., 22: 699-705, 2008.
5. 5) Hoffman, A., et al.: Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations. Cancer, 119: 1868-1877, 2013.